Beta blockade during and after myocardial infarction: an overview of the randomized trials

S Yusuf, R Peto, J Lewis, R Collins, P Sleight - Progress in cardiovascular …, 1985 - Elsevier
An imbalance in oxygen supply and demand......................................................................... 337
Experimental evidence for possible mechanisms of benefit from beta blockade in acute MI …

Part 10: acute coronary syndromes: 2010 American Heart Association guidelines for cardiopulmonary resuscitation and emergency cardiovascular care

RE O'Connor, W Brady, SC Brooks, D Diercks, J Egan… - Circulation, 2010 - Am Heart Assoc
The 2010 AHA Guidelines for CPR and ECC for the evaluation and management of acute
coronary syndromes (ACS) are intended to define the scope of training for healthcare …

[HTML][HTML] I Diretriz de ressuscitação cardiopulmonar e cuidados cardiovasculares de emergência da Sociedade Brasileira de Cardiologia

MM Gonzalez, S Timerman… - Arquivos brasileiros de …, 2013 - SciELO Brasil
Esta edição traz as Diretrizes Brasileiras sobre o Manejo da Ressuscitação Cardiopulmonar
(RCP). Embora a ressuscitação tenha uma longa história que remonta aos tempos bíblicos …

The real role of β-blockers in daily cardiovascular therapy

CA Dézsi, V Szentes - American Journal of Cardiovascular Drugs, 2017 - Springer
The role of β-adrenoceptor antagonists (β-blockers) in cardiovascular therapy has been
subject to diverse trends and changes over the decades. With the advent of a wide variety of …

Primary prevention with metoprolol in patients with hypertension: mortality results from the MAPHY study

J Wikstrand, I Warnold, G Olsson, J Tuomilehto… - Jama, 1988 - jamanetwork.com
The present study of primary prevention in white men aged 40 to 64 years attempts to
investigate whether a β-blocker given as initial antihypertensive treatment would lower total …

MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection

Y Lu, Y Zhang, H Shan, Z Pan, X Li, B Li… - Cardiovascular …, 2009 - academic.oup.com
Aims The present study was designed to investigate whether the beneficial effects of β-
blocker propranolol are related to regulation of microRNA miR-1. Methods and results We …

Antiarrhythmic mechanisms of beta blocker therapy

E Grandi, CM Ripplinger - Pharmacological research, 2019 - Elsevier
Sympathetic activity plays an important role in modulation of cardiac rhythm. Indeed, while
exerting positive tropic effects in response to physiologic and pathologic stressors, β …

Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency

M Tonelli, C Bohm, S Pandeya, J Gill, A Levin… - American Journal of …, 2001 - Elsevier
Cardiovascular disease (CVD) is a major cause of morbidity and mortality among patients
with chronic renal insufficiency (CRI). β-Adrenergic blockers, acetylsalicylic acid (ASA) …

Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis

M Dahl Aarvik, I Sandven, TB Dondo… - European Heart …, 2019 - academic.oup.com
Aims Guidelines concerning β-blocker treatment following acute myocardial infarction (AMI)
are based on studies undertaken before the implementation of reperfusion and secondary …

Beta3-Adrenoreceptor Stimulation Ameliorates Myocardial Ischemia-Reperfusion Injury Via Endothelial Nitric Oxide Synthase and Neuronal Nitric Oxide Synthase …

JP Aragón, ME Condit, S Bhushan, BL Predmore… - Journal of the American …, 2011 - jacc.org
Objectives: This paper examined whether nebivolol protects the heart via nitric oxide (NO)
synthase and NO-dependent signaling in an in vivo model of acute myocardial infarction …